These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 35202189)

  • 1. Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience.
    Elboga U; Sahin E; Cayirli YB; Okuyan M; Aktas G; Haydaroglu Sahin H; Dogan I; Kus T; Akkurd DM; Cimen U; Mumcu V; Kilbas B; Celen YZ
    Tomography; 2022 Feb; 8(1):293-302. PubMed ID: 35202189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.
    Shu Q; Deng M; Hu M; Liu M; Chen X; Chen Y; Cai L
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1442-1452. PubMed ID: 36609606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.
    Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G
    Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.
    Gündoğan C; Kömek H; Can C; Yildirim ÖA; Kaplan İ; Erdur E; Poyraz K; Güzel Y; Oruç Z; Çakabay B
    Nucl Med Commun; 2022 Jan; 43(1):64-72. PubMed ID: 34661379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.
    Guo C; Liu Y; Yang H; Xia Y; Li X; Chen L; Feng Y; Zhang Y; Chen Y; Huang Z
    Br J Radiol; 2024 Mar; 97(1156):859-867. PubMed ID: 38290775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/CT in Patients With SAPHO Syndrome.
    Wang P; Li C; Hou G; Li Z; Jing H; Zhang W; Li F
    Clin Nucl Med; 2023 Sep; 48(9):781-784. PubMed ID: 37543757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer.
    Wegen S; Roth KS; Weindler J; Claus K; Linde P; Trommer M; Akuamoa-Boateng D; van Heek L; Baues C; Schömig-Markiefka B; Schomäcker K; Fischer T; Drzezga A; Kobe C; Köhler C; Marnitz S
    Clin Nucl Med; 2023 Feb; 48(2):150-155. PubMed ID: 36607364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study.
    Zheng S; Lin J; Zhu Y; Chen Y; Zhang J; Chen X; Miao W
    Clin Nucl Med; 2023 Mar; 48(3):e104-e109. PubMed ID: 36723892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of
    Elboga U; Sahin E; Kus T; Cayirli YB; Aktas G; Okuyan M; Cinkir HY; Teker F; Sever ON; Aytekin A; Yılmaz L; Aytekin A; Cimen U; Mumcu V; Kilbas B; Eryilmaz K; Cakici D; Celen YZ
    Mol Imaging Biol; 2022 Oct; 24(5):789-797. PubMed ID: 35411447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Head-to-Head Comparison of 68Ga-LNC1007 and 2-18F-FDG/68Ga-FAPI-02 PET/CT in Patients With Various Cancers.
    Zang J; Lin R; Wen X; Wang C; Zhao T; Jakobsson V; Yang Y; Wu X; Guo Z; Chen X; Zhang J; Miao W
    Clin Nucl Med; 2023 Oct; 48(10):861-868. PubMed ID: 37682601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Mu X; Huang X; Jiang Z; Li M; Jia L; Lv Z; Fu W; Mao J
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1205-1215. PubMed ID: 36495325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions.
    Erol Fenercioğlu Ö; Beyhan E; Şahin R; Baloğlu MC; Arslan E; Çermik TF; Ergül N
    Nucl Med Commun; 2023 Oct; 44(10):896-899. PubMed ID: 37450605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Added Value of
    Gu B; Xu X; Zhang J; Ou X; Xia Z; Guan Q; Hu S; Yang Z; Song S
    J Nucl Med; 2022 Jun; 63(6):875-881. PubMed ID: 34593594
    [No Abstract]   [Full Text] [Related]  

  • 17. Superiority of [
    Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
    Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Gastric Kaposi Sarcoma.
    Tatar G; Beyhan E; Erol Fenercioğlu Ö; Arslan E; Çermik TF
    Clin Nucl Med; 2022 Sep; 47(9):e596-e599. PubMed ID: 35930714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head Intra-individual Comparison of [
    Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
    Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.